← Leaderboards
William E Goldman
Washington University
$11,493,195
Attributed
$11,811,503
Total exposure
14
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$11,811,503 · 14
By mechanism
R01$6,850,219 · 3
R21$1,657,434 · 4
P01$1,164,986 · 1
U54$1,107,592 · 1
P50$654,873 · 1
R56$370,000 · 1
Top collaborators
- Daniel Matute1 shared
Most similar at Washington University
Same institution · by research overlap
- Virginia L Miller$17,757,785
Others in their field
Top investigators on “Virulence”
- Ronald B Corley · Boston University Medical Campus$43,000,000
- Joseph Heitman · Duke University$29,765,716
- Vanessa Sperandio · University Of Wisconsin-Madison$29,177,087
- Adolfo Garcia-Sastre · Jackson Laboratory$28,883,338
- John J Mekalanos · Harvard Medical School$28,747,360
- Scott J Hultgren · Washington University$28,322,020
Research focus
VirulenceMacrophageGenesLungHistoplasmaMutantPathogenGene ExpressionInfectionOrganismPathogenesisMutagenesisLaboratory MouseYeastsHistoplasmosisTissue /Cell CultureBiological ModelsPhenotypeMolecular GeneticsRegulationIntracellular ParasitismPathologic ProcessMouse ModelGenetic
Grant awards (40)
The evolution of virulence in the fungal pathogen Histoplasma$636,617
R01 · FY2021 · AI · contact PI
Discovering Histoplasma factors required for initial macrophage interaction$190,000
R21 · FY2018 · AI · contact PI
Evaluating the Role of Neutrophils in the Progression of Pneumonic Plague$188,217
R21 · FY2018 · AI · contact PI
Discovering Histoplasma factors required for initial macrophage interaction$228,000
R21 · FY2017 · AI · contact PI
Evaluating the Role of Neutrophils in the Progression of Pneumonic Plague$226,217
R21 · FY2017 · AI · contact PI
Early Events in the Pathogenesis of Pneumonic Plague$228,000
R21 · FY2014 · AI · contact PI
Controlling the progression of pneumonic plague$223,476
U54 · FY2013 · AI · contact PI
Role and Regulation of a Molecular Mimic in Histoplasma Pathogenesis$222,000
R21 · FY2013 · AI · contact PI
Early Events in the Pathogenesis of Pneumonic Plague$190,000
R21 · FY2013 · AI · contact PI
Controlling the progression of pneumonic plague$235,188
U54 · FY2012 · AI · contact PI
Role and Regulation of a Molecular Mimic in Histoplasma Pathogenesis$185,000
R21 · FY2012 · AI · contact PI
Molecular Mechanisms of Histoplasma Pathogenesis$370,000
R56 · FY2011 · AI · contact PI
Controlling the progression of pneumonic plague$223,877
U54 · FY2011 · AI · contact PI
Controlling the progression of pneumonic plague$302,610
U54 · FY2010 · AI · contact PI
Controlling the progression of pneumonic plague$122,441
U54 · FY2009 · AI · contact PI
ROLE OF CALCIUM-BINDING PROTEIN AND FUNCTION IN LUNG DISEASE$1,050
P41 · FY2009 · RR · contact PI
Alpha-(1,3)-Glucan as a Target for Antifungal Therapy$233,811
P01 · FY2008 · AI · contact PI
Molecular Mechanisms of Histoplasma Pathogenesis$203,460
R01 · FY2008 · AI · contact PI
Molecular Mechanisms of Histoplasma Pathogenesis$143,760
R01 · FY2008 · AI · contact PI
ROLE OF CALCIUM-BINDING PROTEIN AND FUNCTION IN LUNG DISEASE$425
P41 · FY2008 · RR · contact PI
Molecular Mechanisms of Histoplasma Pathogenesis$362,679
R01 · FY2007 · AI · contact PI
Alpha-(1,3)-Glucan as a Target for Antifungal Therapy$231,669
P01 · FY2007 · AI · contact PI
Comparative Genomics of Histoplasma and Blastomyces$680,123
R01 · FY2006 · AI · contact PI
Molecular Mechanisms of Histoplasma Pathogenesis$373,511
R01 · FY2006 · AI · contact PI
Alpha-(1,3)-Glucan as a Target for Antifungal Therapy$237,276
P01 · FY2006 · AI · contact PI
LOCATING DISULFIDE BONDS IN CALCIUM-BINDING PROTEIN$4,924
P41 · FY2006 · RR · contact PI
Comparative Genomics of Histoplasma and Blastomyces$691,387
R01 · FY2005 · AI
Molecular Mechanisms of Histoplasma Pathogenesis$382,500
R01 · FY2005 · AI
ROLE OF NITRIC OXIDE AND INTERLEUKIN 1$271,250
P50 · FY2005 · HL
Alpha-(1,3)-Glucan as a Target for Antifungal Therapy$230,365
P01 · FY2005 · AI
Comparative Genomics of Histoplasma and Blastomyces$624,253
R01 · FY2004 · AI
Molecular Mechanisms of Histoplasma Pathogenesis$382,500
R01 · FY2004 · AI
Alpha-(1,3)-Glucan as a Target for Antifungal Therapy$231,865
P01 · FY2004 · AI
Comparative Genomics of Histoplasma and Blastomyces$649,470
R01 · FY2003 · AI
Comparative Genomics of Histoplasma and Blastomyces$732,056
R01 · FY2002 · AI
MOLECULAR MECHANISMS OF HISTOPLASMA PATHOGENESIS$339,082
R01 · FY2002 · AI
ROLE OF NITRIC OXIDE AND INTERLEUKIN 1$172,411
P50 · FY2002 · HL
MOLECULAR MECHANISMS OF HISTOPLASMA PATHOGENESIS$329,205
R01 · FY2001 · AI
MOLECULAR MECHANISMS OF HISTOPLASMA PATHOGENESIS$319,616
R01 · FY2000 · AI
ROLE OF NITRIC OXIDE AND INTERLEUKIN 1$211,212
P50 · FY2000 · HL